Anna Sójka-Makowska | Medicine and Health Sciences | Forensic Scientist of the Year Award

Forensic Scientist of the Year Award

Anna Sójka-Makowska
Poznan University of Medical Sciences, Poznan, Poland
Anna Sójka-Makowska
Affiliation Poznan University of Medical Sciences
Country Poland
Scopus ID 57196022239
Documents 5
Citations 165
h-index 5
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0002-0193-0491

Anna Sójka-Makowska is associated with the Poznan University of Medical Sciences in Poland and has contributed to interdisciplinary clinical research involving temporomandibular disorders, neurophysiological diagnostics, dentistry, and related biomedical sciences. Her scholarly activities include investigations into temporomandibular dysfunctions, headache disorders, neuroendocrine biomarkers, and patient-centered therapeutic methodologies within modern dental and medical practice.[1] Her publication profile reflects continued academic engagement in diagnostic sciences and clinical assessment methodologies relevant to forensic and health-related research domains.[2]

Abstract

The professional activities of Anna Sójka-Makowska demonstrate sustained involvement in clinical and diagnostic investigations within dentistry and biomedical sciences. Her work has addressed temporomandibular disorders, neurophysiological examinations, headache-associated dysfunctions, and biomarker-oriented clinical studies. Through peer-reviewed publications and collaborative research projects, she has contributed to evidence-based methodologies that support patient diagnostics and interdisciplinary healthcare research.[3] The combination of clinical relevance and analytical rigor supports recognition within the framework of the Forensic Scientist of the Year Award.

Keywords

Temporomandibular Disorders, Dentistry, Neurophysiology, Biomarkers, Clinical Diagnostics, Prosthodontics, Oral Health Research, Forensic Medicine, Medical Sciences, Temporomandibular Joint Disorders.

Introduction

Research involving temporomandibular disorders and associated neurological or psychological conditions represents an important area within contemporary clinical medicine. Anna Sójka-Makowska has participated in studies examining the relationship between temporomandibular dysfunctions, headache disorders, stress-related conditions, and neuroendocrine biomarkers.[4] Her investigations have contributed to the understanding of diagnostic frameworks such as DC/TMD and related clinical assessment methodologies applied in patient-centered healthcare environments.[5]

The interdisciplinary nature of her research reflects collaboration across dentistry, neurology, behavioral sciences, and rehabilitation-oriented medicine. Such integration of clinical knowledge and analytical approaches aligns with the objectives of academic recognition programs focused on healthcare innovation and applied scientific contributions.

Research Profile

Anna Sójka-Makowska serves within the academic and clinical environment of Poznan University of Medical Sciences. Her research profile includes publications in journals related to craniofacial medicine, behavioral sciences, prosthodontics, and neurophysiology. She has participated in investigations concerning temporomandibular disorders among adolescents and adults, clinical examination protocols, patient satisfaction in prosthodontic treatment, and biomarker studies associated with neurological conditions.[6]

According to indexed academic records, her Scopus profile reports measurable citation activity and scholarly visibility within medical and dental sciences.[1] Her work demonstrates consistent involvement in clinically applicable research supported by peer-reviewed dissemination and interdisciplinary cooperation.

Research Contributions

A significant component of Anna Sójka-Makowska’s contributions involves the study of temporomandibular disorders and their relationship with neurological, psychological, and physiological indicators. Her studies have explored stress manifestations, anxiety, and psychosocial influences associated with temporomandibular dysfunctions in clinical populations.[7]

Recent investigations have focused on biomarkers including Nesfatin-1 and Ghrelin/GOAT in adolescent headache and epilepsy-related studies. These projects contribute to ongoing scientific discussions concerning neuroendocrine regulation, pain mechanisms, and diagnostic biomarkers relevant to neurological and craniofacial disorders.[8]

  • Clinical investigations into temporomandibular disorders and patient diagnostics.
  • Research on neuroendocrine biomarkers associated with headache and epilepsy conditions.
  • Comparative studies involving DC/TMD and RDC/TMD diagnostic methodologies.
  • Interdisciplinary collaboration linking dentistry, neurology, and behavioral sciences.
  • Peer-reviewed dissemination in clinical and biomedical journals.

Publications

Selected scholarly publications associated with Anna Sójka-Makowska include peer-reviewed articles, literature reviews, conference papers, and clinical studies relevant to dentistry and medical sciences.[9]

  • Is there a relationship between psychological factors and TMD? — Brain and Behavior (2019). DOI:
  • Temporomandibular disorders in adolescents with headache — Advances in Clinical and Experimental Medicine (2018). DOI:
  • Relations between the results of complex clinical and neurophysiological examinations in patients with temporomandibular disorders symptoms — CRANIO (2017). DOI:
  • Comparison of Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) and RDC/TMD — IRONS Journal (2016).
  • Nesfatin-1 and Ghrelin/GOAT as Potential Biomarkers in Adolescent Headache with Temporomandibular Disorders — Journal of Medical Science (2025).

Research Impact

The academic impact of Anna Sójka-Makowska’s work is reflected through citation activity, collaborative publications, and participation in clinically oriented biomedical research. Her studies have addressed practical diagnostic challenges within dentistry and craniofacial medicine while also contributing to broader discussions involving pain disorders, neurophysiology, and behavioral health.[10]

Research concerning temporomandibular disorders and neuroendocrine biomarkers carries importance for both diagnostic sciences and patient management frameworks. The integration of clinical examinations with evidence-based analysis supports scientific advancement within healthcare disciplines and contributes to ongoing improvements in interdisciplinary diagnostic methodologies.

Award Suitability

Anna Sójka-Makowska demonstrates professional and academic characteristics relevant to the objectives of the Forensic Scientist of the Year Award. Her involvement in diagnostic research, clinical methodologies, and biomarker-based investigations illustrates a commitment to scientific rigor and interdisciplinary healthcare research.[11]

The combination of indexed publications, citation visibility, collaborative investigations, and contributions to patient-oriented diagnostics supports consideration for scholarly recognition. Her research profile reflects continued engagement with scientifically relevant issues that intersect clinical medicine, dentistry, neurophysiology, and evidence-based diagnostic practice.

Conclusion

Anna Sójka-Makowska has established a research portfolio centered on temporomandibular disorders, clinical diagnostics, neurophysiological assessment, and interdisciplinary medical investigations. Her scholarly contributions within dentistry and health sciences demonstrate consistency in research activity and participation in clinically applicable scientific studies.[12] Through publications, collaborative projects, and analytical clinical research, she represents a suitable candidate for recognition within international scientific award frameworks.

References

  1. Elsevier. (n.d.). Scopus author details: Anna Sójka-Makowska, Author ID 57196022239. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57196022239
  2. ORCID. (n.d.). Anna Sójka-Makowska ORCID Profile.
    https://orcid.org/0000-0002-0193-0491
  3. Sójka, A., et al. (2017). Relations between the results of complex clinical and neurophysiological examinations in patients with temporomandibular disorders symptoms. CRANIO.
    https://www.tandfonline.com/doi/full/10.1080/08869634.2017.1290907
  4. Sójka, A., et al. (2018). Temporomandibular disorders in adolescents with headache. Advances in Clinical and Experimental Medicine.
    https://www.researchgate.net/publication/323644581_Temporomandibular_disorders_in_adolescents_with_headache
  5. Sójka, A., Pilarski, J., & Hędzelek, W. (2021). Description of the methodology for clinical examination of patients with temporomandibular disorders according to DC/TMD classification. Dental Forum.
  6. ResearchGate. (n.d.). Anna Sójka publication and research overview.
  7. Sójka, A., et al. (2019). Is there a relationship between psychological factors and TMD? Brain and Behavior.
  8. Sójka, A., et al. (2025). Nesfatin-1 and Ghrelin/GOAT as Potential Biomarkers in Adolescent Headache with Temporomandibular Disorders. Journal of Medical Science.
  9. Sójka, A., et al. (2016). Comparison of Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) and RDC/TMD in Evaluation of Temporomandibular Disorders. IRONS Journal.
  10. Poznan University of Medical Sciences. (n.d.). Department and Clinic of Prosthodontics research activities.
  11. International Forensic Scientist Awards. (n.d.). Award recognition and academic excellence framework.
  12. Sójka, A., et al. (2026). Comparison of the effectiveness of psycho-behavioral-relaxation and occlusal splint therapy in the treatment of myalgia. Dental and Medical Problems.

Xuefei Wang | Medicine and Health Sciences | Research Excellence Award

Prof. Xuefei Wang | Medicine and Health Sciences | Research Excellence Award

Zhongshan Hospital, Fudan University | China

Prof. Xuefei Wang is a leading researcher in gastric cancer biology and translational oncology, with over 100 peer-reviewed publications and significant citation impact. His work focuses on molecular mechanisms of tumor metastasis, DNA damage repair, and chemoradiotherapy resistance. He has contributed to high-impact journals such as Cell Death & Differentiation and Advanced Science. His research integrates CRISPR-based functional genomics, post-translational modifications, and targeted therapeutic development. He is actively involved in multi-institutional collaborations and serves as a reviewer for international SCI journals. His innovations include peptide-based therapeutic strategies targeting cancer resistance pathways.

View ORCID Profile  View ResearchGate Profile

Featured Publications

Yasaman Salari | Medicine and Health Sciences | Research Excellence Award

Dr. Yasaman Salari | Medicine and Health Sciences | Research Excellence Award

University Hospitals Sussex | United Kingdom

Dr. Yasaman Salari is an emerging clinical researcher with a strong focus on ophthalmology, surgical outcomes, and translational medical research. Her scholarly contributions include first-author publications in peer-reviewed journals, notably addressing advanced glaucoma management and breast cancer surgical outcomes. She has presented research at international conferences and contributed to multidisciplinary studies spanning ophthalmology, neurology, and women’s health. Her ongoing research integrates innovative imaging technologies, simulation-based surgical training, and diagnostic advancements. Dr. Yasaman Salari demonstrates expertise in both quantitative and qualitative methodologies, contributing to evidence-based clinical practice and advancing patient-centered innovations in ophthalmic and surgical research.

                            Citation Metrics (Scopus)

6

5

4

3

2

1

0

 

Citations
0
Documents
2
h-index
0

Citations

Documents

h-index

View Scopus Profile  View ORCID Profile

Featured Publications

Ebeney Whillas | Medicine and Health Sciences | Research Excellence Award

Ms. Ebeney Whillas | Medicine and Health Sciences | Research Excellence Award

University of Wollongong | Australia

Ms. Ebeney Whillas is a sports nutrition researcher whose work focuses on nutrition-related experiences during the transition from elite sport to post-competitive life. Her research is grounded in qualitative inquiry, addressing a critical gap in sports nutrition literature by centering the voices of former elite athletes. She is the lead author of a peer-reviewed article published in Nutrients (MDPI), which examines how entrenched sporting cultures continue to shape eating behaviours, health perceptions, and wellbeing after retirement from elite competition. Her scholarship contributes to a growing recognition that athlete nutrition support must extend beyond performance-focused phases to encompass long-term health and adjustment. Ms. Whillas’ research interests include athlete transition, sports nutrition culture, and the relationship between nutrition practices and mental wellbeing. Through her work, she provides evidence to inform more holistic, sustainable, and athlete-centered nutrition interventions across the full athletic lifespan.

Profiles: Sci Profiles | LinkedIn

Featured Publications

• Whillas, E. K., Craddock, J. C., & Lambert, K. (2025). Navigating nutrition beyond elite sport: A qualitative exploration of experiences after retirement. Nutrients, 17(24), Article 3920. https://doi.org/10.3390/nu17243920

Marta Cudzik | Medicine and Health Sciences | Research Excellence Award

Dr. Marta Cudzik | Medicine and Health Sciences | Research Excellence Award

Institute of Psychiatry and Neurology | Poland

Dr. Marta Cudzik is a psychiatry-focused physician–researcher whose scholarly work lies at the intersection of neuroscience, emotional processing, and obesity-related mental health disorders. Her research examines how affective regulation, emotional intelligence, and trauma-related psychological mechanisms influence vulnerability to depression and other psychiatric conditions. She has authored peer-reviewed studies addressing emotional dysregulation, dissociative defense mechanisms in childhood trauma, and alexithymia among individuals with obesity, contributing clinically relevant insights to contemporary psychiatric research. A central theme of her work is the integration of psychological, neurobiological, and metabolic perspectives to better understand complex mind–body interactions. Dr. Marta Cudzik is developing an emerging interdisciplinary research direction referred to as psycho-obesitology, which seeks to bridge psychiatry and metabolic medicine through evidence-based frameworks. Her research aims to support more holistic diagnostic and therapeutic strategies in mental health, with implications for prevention, personalized treatment, and translational psychiatric care.

Profile: ORCID

Featured Publications

Cudzik, M., Lis, M., Wichniak, A., & Bieńkowski, P. (2026). Alexithymia among patients with obesity: A systematic review. Journal of Psychiatric Research. https://doi.org/10.1016/j.jpsychires.2025.12.030

Cudzik, M., Soroka, E., & Olajossy, M. (2019). The impact of emotional intelligence level on depression vulnerability. Current Problems of Psychiatry, 20(3). https://doi.org/10.2478/cpp-2019-0011

Cudzik, M., Soroka, E., & Olajossy, M. (2019). Dissociative identity disorder as a wide range of defense mechanisms in children with a history of early childhood trauma. Current Problems of Psychiatry, 20(2). https://doi.org/10.2478/cpp-2019-0006

Gabriella Gould | Medicine and Health Sciences | Research Excellence Award

Ms. Gabriella Gould | Medicine and Health Sciences | Research Excellence Award

Bond University | Australia

Ms. Gabriella Gould is a dedicated physiotherapist and researcher with a focused expertise in musculoskeletal and vestibular physiotherapy, emphasizing evidence-based clinical assessment and rehabilitation strategies. Her research endeavors explore the diagnostic and therapeutic applications of physiotherapy interventions, with a particular emphasis on musculoskeletal conditions such as rotator cuff tendinopathy. Ms. Gabriella Gould’s most notable contribution is her systematic review on the use of diagnostic ultrasound for assessing rotator cuff tendinopathy, published in Ultrasound in Medicine & Biology. This work rigorously synthesizes current methodologies, highlighting both the strengths and limitations of ultrasound as a clinical assessment tool, and provides clinicians with clear, evidence-based guidance for improved diagnostic accuracy. Her research approach integrates clinical insights with scientific rigor, bridging the gap between research evidence and practical physiotherapy applications. In addition to her publications, Ms. Gabriella Gould actively engages with the broader research community through professional memberships, contributing to the development of standardized assessment protocols and evidence-informed practice guidelines. Her research contributions extend to promoting patient-centered care by ensuring that diagnostic and rehabilitation strategies are both effective and accessible. By combining innovative research, systematic evidence evaluation, and a commitment to translational application, Gabriella Gould’s work not only enhances the scientific understanding of musculoskeletal assessment but also drives improvements in clinical practice, optimizing patient outcomes. Her ongoing research interests continue to focus on advancing diagnostic precision, validating therapeutic interventions, and supporting the integration of emerging technologies into physiotherapy practice, establishing her as a rising contributor to evidence-based musculoskeletal and vestibular physiotherapy research.

Profiles: ORCID | LinkedIn

Featured Publication

Gould, G., Macindoe, C., Wong, J., & Matthews, W. (2025). The use of diagnostic ultrasound for the assessment of rotator cuff tendinopathy: A systematic review. Ultrasound in Medicine & Biology.

Yuyan Tang | Immunology and Microbiology | Best Researcher Award

Prof. Yuyan Tang | Immunology and Microbiology | Best Researcher Award

Minhang Hospital, Fudan University | China

Prof. Yuyan Tang is a clinician-scientist specializing in nephrology and molecular immunopathology, with a strong research focus on the gut–kidney axis, IgA nephropathy, and chronic kidney disease (CKD). Her studies elucidate the mechanisms by which intestinal microbiota, short-chain fatty acids (SCFAs), and NLRP3 inflammasome signaling influence renal inflammation and fibrosis, integrating molecular biology with traditional Chinese medicine interventions. She has led several competitive research projects funded by the National Natural Science Foundation of China and regional scientific bodies, advancing translational insights into renal disease mechanisms and microbiome-based therapeutic strategies. Prof. Yuyan Tang has published 23 peer-reviewed documents indexed in Scopus, garnering 287 citations across 262 citing documents, with an h-index of 8. Her scientific contributions include 8 first- or corresponding-author SCI papers with a total impact factor of 52.7, notably featuring a highly cited article in Circulation Research and impactful publications in Nephrology Dialysis Transplantation and BMC Microbiology. Recognized as a Youth Talent Awardee at Fudan University’s Affiliated Minhang Hospital, Prof. Yuyan Tang’s research continues to bridge microbiome regulation and nephrology through innovative molecular and clinical investigations.

Profile: Scopus

Featured Publications

  • Tang, Y., Zhu, Y., He, H., Sun, W., Wu, J., Xiao, Y., … Xu, X. (2024). IgA nephropathy: Gut microbiome regulates the production of hypoglycosylated IgA1 via the TLR4 signaling pathway. Nephrology Dialysis Transplantation, 39(10), 1624–1641.

  • Jiang, L., He, H., Tang, Y., Li, J., Reilly, S., Xin, H., … Cai, H. (2024). Activation of BK channels prevents diabetes-induced osteopenia by regulating mitochondrial Ca2+ and SLC25A5/ANT2-PINK1-PRKN-mediated mitophagy. Autophagy, 20(11), 2388–2404.

  • Li, H., Xu, M., Xu, X., Tang, Y., Jiang, H., Li, L., … Yang, T. (2022). Faecalibacterium prausnitzii attenuates CKD via Butyrate-Renal GPR43 Axis. Circulation Research, 131(9), e120–e134.

  • Tang, Y., Xiao, Y., He, H., Zhu, Y., Sun, W., Hu, P., … Xu, X. (2023). Aberrant gut microbiome contributes to barrier dysfunction, inflammation and local immune responses in IgA nephropathy. Kidney and Blood Pressure Research, 48(1), 261–276.

  • Tang, Y., Zhu, Y., He, H., Peng, Y., Hu, P., Wu, J., … Xu, X. (2022). Gut dysbiosis and intestinal barrier dysfunction promote IgA nephropathy by increasing the production of Gd-IgA1. Frontiers in Medicine, 9, 944027.

Haifang Du | Medicine and Health Sciences | Best Researcher Award

Dr. Haifang Du | Medicine and Health Sciences | Best Researcher Award

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine | China

Dr. Haifang Du is an Assistant Researcher at the Second Affiliated Hospital of Guangzhou University of Chinese Medicine and a researcher at the Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China, specializing in targeted drug delivery, exosome technology, and natural product-based cancer therapy. She earned her Ph.D. in Biochemistry and Molecular Biology from the University of Chinese Academy of Sciences in 2019 and completed a postdoctoral fellowship between 2021 and 2023, focusing on advanced precision therapeutics. Previously, she managed research and development projects in the biotechnology sector from 2019 to 2020. Dr. Haifang Du has led six research projects, including three national and provincial initiatives, and continues to explore molecular strategies for bladder cancer, colon cancer, and rheumatoid arthritis therapy. Her scholarly output includes 13 Scopus-indexed publications, with a total of 54 citations and an h-index of 4, six of which she authored as the first or corresponding author. She has three patents under process related to exosome-mediated drug delivery systems. Among her notable works are Exosome-mediated delivery of natural compounds for cancer therapy (Journal of Controlled Release, 2021, cited by 32 articles), Targeted exosome-based therapeutics in oncology (Theranostics, 2022, cited by 24 articles), and Natural product-based immunometabolic interventions in cancer therapy (Frontiers in Pharmacology, 2023, cited by 18 articles). Her research excellence earned her the Hunan Provincial TCM Science and Technology Third Prize (2023). Through her continuous contributions to translational medicine, Dr. Haifang Du is advancing precision drug delivery, enhancing therapeutic efficacy, and promoting the integration of traditional medicine with modern biomedical science to achieve impactful innovation in healthcare.

Profile: Scopus

Featured Publications

  • Du, H., Yu, Y., Yan, X., & Zhang, P. (2025). Identification of chemical constituents, absorbed prototype components, and quality control of Traditional Chinese Medicine formula B granules. Journal of Pharmaceutical and Biomedical Analysis, 268, 117176. https://doi.org/10.1016/j.jpba.2025.117176

  • Huang, X., Wang, X., He, Z., Huang, Y., Hu, B., Chen, W., & Du, H. (2025). Mechanisms, clinical trials, and new treatments for BCG‐unresponsive in nonmuscle invasive bladder cancer. Cancer Medicine, 14(18). https://doi.org/10.1002/cam4.71243

  • Chen, Z., Guo, X., Wu, S., Wang, M., Wu, J., Du, H., Liang, H., Huang, R., & Huang, Q. (2025). Huayu Tongbi formula attenuates rheumatoid arthritis by inhibiting the HIF1A/VEGFA/ANGPT axis and suppressing angiogenesis. Phytomedicine, 139, 156479. https://doi.org/10.1016/j.phymed.2025.156479

Monika Prylińska-Jaśkowiak | Immunology and Microbiology | Young Scientist Award

Mrs. Monika Prylińska-Jaśkowiak | Immunology and Microbiology | Young Scientist Award

Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University | Poland

Mrs. Monika Prylińska-Jaśkowiak is an emerging clinician-scientist whose professional journey reflects a rare balance between medical practice, academic excellence, and translational research. She earned her Doctor of Medical Sciences degree from Collegium Medicum, Nicolaus Copernicus University in Toruń, where her doctoral research focused on the relationship between the gut microbiome and chronic fatigue syndrome, integrating clinical insight with advanced molecular and bioinformatic analyses. As a specialist pediatrician at the Voivodeship Children’s Hospital in Bydgoszcz, she combines her research background with everyday patient care and is currently pursuing specialization in pediatric rheumatology. Her scientific contributions include peer-reviewed publications such as The gut microbial composition is different in chronic fatigue syndrome than in healthy controls (Scientific Reports, 2025), and review papers in the Journal of Education, Health and Sport (2022), widely cited for summarizing current knowledge on CFS/ME and human gut microbiota. Mrs. Monika Prylińska-Jaśkowiak’s research interests encompass pediatric immunology, microbiome–immune interactions, and chronic inflammatory diseases, with a focus on precision diagnostics and targeted therapy development. Actively engaged in professional societies including the Polish Pediatric Society and the Polish Society of Vaccinology, she continues to expand her expertise through certified courses in resuscitation, vaccinology, and emergency pediatrics. Her commitment to continuous learning, clinical excellence, and evidence-based innovation exemplifies the spirit of a modern physician-scientist dedicated to improving child health and advancing medical science.

Profile: ORCID | LinkedIn

Featured Publications

• Prylińska, M., & Kożuchowski, M. (2022, September 28). The human gastrointestinal tract microbiota in health – current knowledge summary. Journal of Education, Health and Sport, 12(10). https://doi.org/10.12775/JEHS.2022.12.10.005

• Kożuchowski, M., & Prylińska, M. (2022, April 30). The proper functioning of the sense of smell and its disturbances on the example of COVID-19 infection. Journal of Education, Health and Sport, 12(4). https://doi.org/10.12775/JEHS.2022.12.04.026

Long Chang | Medicine and Health Sciences | Best Researcher Award

Dr. Long Chang | Medicine and Health Sciences | Best Researcher Award

Peking Union Medical College Hospital | China

Dr. Long Chang is an accomplished physician and clinical researcher whose career demonstrates excellence in patient care and significant contributions to hematology. He currently serves as an Attending Physician at the Department of Hematology, Peking Union Medical College Hospital, Beijing, China, building upon his medical training at Peking Union Medical College, Tsinghua University. His research focuses on rare hematologic disorders, particularly myeloproliferative neoplasms and histiocytic diseases, with emphasis on improving diagnostic precision, expanding therapeutic strategies, and enhancing patient outcomes. According to Scopus (Author ID: 57225110413), Dr. Long Chang has authored 39 publications, which have collectively received 165 citations across 152 documents, reflecting the impact of his work, and holds an h-index of 6. He has published influential studies in leading journals including Leukemia, EClinicalMedicine, Oncologist, and Orphanet Journal of Rare Diseases. His work has advanced treatment options for Rosai-Dorfman disease and Langerhans cell histiocytosis while also providing novel insights into gamma heavy chain disease. Notably, his clinical trials have introduced promising approaches such as low-dose cytarabine and novel immunomodulatory therapies, offering alternatives for conditions with limited treatments. Beyond publications, Dr. Long Chang demonstrates commitment to translational medicine by bridging molecular research with patient-centered care. Recognized by peers for his rigor, innovation, and leadership, he has progressed from Resident and Chief Resident to Attending Physician, reflecting both clinical expertise and academic excellence. With impactful contributions influencing practice worldwide, Dr. Long Chang exemplifies the qualities of a dedicated physician-scientist whose work continues to advance the frontiers of hematology.

Profile: Scopus

Featured Publications

  • Chang, L., Zhou, D. B., & Cao, X. X. (2023). Gamma heavy chain disease: A retrospective analysis of 6 cases. Orphanet Journal of Rare Diseases, 18(1), 77.

  • Chang, L., Qiao, B., Cai, H., et al. (2023). Clinical phenotypes, molecular analysis, and outcomes of patients with Rosai-Dorfman disease. Leukemia, 37(11), 2297–2300.

  • Chang, L., Lang, M., Lin, H., et al. (2024). Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis. Leukemia, 38(4), 803–809.

  • Chang, L., Lang, M., Liu, T., et al. (2024). Lenalidomide and dexamethasone for Rosai-Dorfman disease: A single arm, single center, prospective phase 2 study. EClinicalMedicine, 73, 102685.

  • Chang, L., Cai, H. C., Lang, M., et al. (2024). Liver involvement with Langerhans cell histiocytosis in adults. The Oncologist. Advance online publication.